Genevive: Pioneering Next-Generation Medicines Inspired by the Microbiome

Genevive engineers microbiome-inspired medicines. Our discovery platform uses data science and high-throughput screening to identify bioactive compounds capable of modulating inflammation, autoimmunity, metabolic disease, oncology, and neurological conditions.

Karim Dabbagh, PhD

Co-Founder, Executive Chairman

Joe Dal Porto, PhD

Co-Founder, President, Chief Scientific Officer

Todd DeSantis

Co-Founder, Head of Informatics and Platform Development

Jose Carlos Gutierrez-Ramos, PhD

Chief Science Officer, Danaher Corporation

Shann Yu, PhD

Abbvie Ventures

Silvio Danese, MD PhD

Professor and Head of Gastroenterology, Humanitas, Milan Italy

Balfour Sartor, MD PhD

Professor of Medicine (GI)